Natasha Gloeck
Datos Biográficos
| ID | 9064192 |
|---|---|
| NOMBRE | Natasha Gloeck |
| NOMBRES | Natasha |
| APELLIDO | Gloeck |
| FIRMA | GLOECK N |
| VERIFICADO | No |
| TOTAL DE OBRAS | 1 |
| TOTAL DE CITAS | 0 |
| TOTAL COMO AUTOR | 1 |
| TOTAL COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 2023 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2023 |
| ÍNDICE H | 0 |
Effectiveness of the BNT162b2 vaccine in preventing morbidity and mortality associated with Covid-19 in children aged 5 to 11 years
A rapid systematic review, based on Cochrane rapid review methodology was conducted to assess the effectiveness of two 10μg doses of BNT162b2 vaccine in preventing morbidity and mortality associated with COVID-19 in children aged 5 to 11 years. We searched the Cochrane Library COVID-19 study register, the COVID-NMA living review database and the McMaster University Living Evidence Synthesis for pre-appraised trials and observational studies up to…
Sin obras prominentes en esta página.
Effectiveness of the BNT162b2 vaccine in preventing morbidity and mortality associated with Covid-19 in children aged 5 to 11 years
A rapid systematic review, based on Cochrane rapid review methodology was conducted to assess the effectiveness of two 10μg doses of BNT162b2 vaccine in preventing morbidity and mortality associated with COVID-19 in children aged 5 to 11 years. We searched the Cochrane Library COVID-19 study register, the COVID-NMA living review database and the McMaster University Living Evidence Synthesis for pre-appraised trials and observational studies up to…